NeoLight, an empathy-driven medical device company that designs, engineers, and manufactures technologies to treat infants with life-threatening medical conditions, announces today interim data from an ongoing clinical study on the efficacy of NeoLight’s Skylife™, a neonatal phototherapy device recently cleared by the U.S. Food and Drug Administration (FDA) to treat hyperbilirubinemia, commonly known as Jaundice.
